Condition 1: Nausea and vomiting. Condition 2: Anxiety. Nausea and vomiting Anxiety disorder due to known physiological condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients over 18 years Patients with breast and esophageal, gastric and intestinal cancers (due to the same drugs used) Healthy sense of smell: Measurement by smelling alcohol No history of asthma or chronic obstructive pulmonary disease Lack of sensitivity to plant essential oils Having a minimum nausea score of 2 based on vas criteria on the first day of study No more anxiety score of 63 Do not take sedatives or other medications (such as using herbal essential oils, regular exercise) to reduce anxiety for six weeks before the intervention Not addicted to drugs Perform chemotherapy once a week Patients with stage I, II cancer The goal of chemotherapy is therapy
Exclusion criteria
Exclusion criteria: Use of other Complementary therapies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea, vomiting. Timepoint: Before and during the intervention. Method of measurement: Visual criteria for nausea and vomiting. | — |
Secondary
| Measure | Time frame |
|---|---|
| A??nxiety. Timepoint: Before and during the study. Method of measurement: Spielberger's Anxiety Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Kashan University of Medical Sciences